Laurus Labs lists with 14.50% premium on the bourses

19 Dec 2016 Evaluate

Laurus Labs debuted at Rs 490.00 on the BSE, up by 62 points or 14.49% from its issue price of Rs 428.

The scrip is currently trading at Rs 476.25, up by 48.25 points or 11.27% from its issue price. It has touched a high and low of Rs 498.00 and Rs 475.00 respectively. So far 19,17,000 shares were traded on the counter.

The offering, which was open for subscription between December 6 and December 8, was subscribed 4.52 times. The issue price was fixed at Rs 428 per share i.e. at upper end of price band of Rs 426-428 apiece.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

570.80 3.65 (0.64%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.